MUMBAI, January 9, 2014 /PRNewswire/ --
Bharat Book Bureau presents Drug Delivery Partnering Terms and Agreements In this report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
This report contains over 2,500 links to online copies of actual drug delivery deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The initial chapters of this report provide an orientation of drug delivery dealmaking and business activities.
- Chapter 1 provides an introduction to the report, whilst
- Chapter 2 provides an overview of the trends in drug delivery dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms.
- Chapter 3 provides a review of the leading drug delivery deals since 2007. Deals are listed by headline value, signed by big pharma, big biotech, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
- Chapter 4 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of drug delivery deals as well as contract documents available in the public domain. Where available, each deal title links via We blink to an online version of the actual contract document, providing easy access to each contract document on demand.
- Chapter 5 provides a comprehensive listing of the top 50 big biotech companies with a brief summary followed by a comprehensive listing of drug delivery deals, as well as contract documents available in the public domain. Where available, each deal title links via We blink to an online version of the actual contract document, providing easy access to each contract document on demand.
- Chapter 6 provides a comprehensive and detailed review of drug delivery partnering deals signed and announced since 2007, where a contract document is available in the public domain. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via We blink to an online version of the deal record and the contract document, providing easy access to each contract document on demand.
- Chapter 7 provides a comprehensive and detailed review of drug delivery partnering deals organized by specific drug delivery technology type. Each deal title links via We blink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in drug delivery partnering and dealmaking since 2007.
Drug Delivery Partnering Terms and Agreements include:
- Trends in drug delivery dealmaking in the biopharma industry since 2007
- Analysis of drug delivery deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life drug delivery deals
- Access to over 2,500 drug delivery contract documents
- The leading drug delivery deals by value since 2007
- Most active drug delivery dealmakers since 2007
- The leading drug delivery partnering resources
Drug Delivery Partnering Terms and Agreements provide the reader with the following key benefits:
- In-depth understanding of drug delivery deal trends since 2007
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of drug delivery agreements with numerous real life case studies
- Comprehensive access to over 2,500 actual drug delivery contracts entered into by the world's biopharma companies
- Detailed access to actual drug delivery contracts enter into by the leading fifty big pharma and big biotech companies
- Insight into the terms included in a drug delivery agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=348528
- Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vials
- Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin Pumps
- The 2013-2018 World Outlook for Pulmonary Drug Delivery Technologies
- The 2013-2018 World Outlook for Intranasal Drug Delivery Applications
About Bharat Book Bureau
Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.
SOURCE Bharat Book Bureau